Biograil
Biograil develops oral capsule technology designed to transform injectable pharmaceutical products into pill-based delivery methods.
Biograil is a biotech & life sciences company based in Copenhagen, DK, founded in 2019. It has raised $22.36 million in disclosed funding. Its latest round was an Undisclosed stage of €20 million in November 2026.
Overview
Biograil is a pre-clinical stage pharmaceutical company focused on drug delivery innovation. Founded in 2019, the startup aims to shift the market for injectable pharmaceutical products toward more convenient, patient-friendly oral delivery methods. Central to its approach is the proprietary BIONDD® technology, which the company uses to engineer specialized oral capsules. By enabling the oral administration of drugs that typically require injection, Biograil seeks to improve patient compliance and therapeutic accessibility. The company operates as a biotech firm and has secured $22.36 million in total funding to support its research and development efforts. Biograil’s leadership team includes CEO and founder Karsten Lindhardt alongside Chief Scientific Officer Nikolaj Skak. Its board features industry veterans and investors, including representatives from organizations such as Verve Ventures, which focus on deep tech and scientific excellence. Through its targeted design and focus on manufacturing, Biograil continues to advance its preclinical pipeline with the goal of solving complex challenges in drug formulation and delivery.
Funding
Total disclosed: $22.4M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Biograil do?
Biograil develops oral capsule technology designed to transform injectable pharmaceutical products into pill-based delivery methods.
How much has Biograil raised?
Biograil has raised $22.36 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Biograil?
Investors in Biograil include Verve Ventures, Megatrend Invest, and High-Tech Gründerfonds.
When and where was Biograil founded?
Biograil was founded in 2019 and is based in Copenhagen, DK.
Timeline
Founded
Sources
- 1.Copenhagen’s Biograil raises €20 million for oral drug delivery device designed as an alternative to injections — EU-Startups, Nov 4, 2026
- 2.Biograil · Official
- 3.Biograil · Official
- 4.Biograil · Official
- 5.Biograil · Official